Rfx5tm1.1Ifo
Targeted Allele Detail
|
Symbol: |
Rfx5tm1.1Ifo |
Name: |
regulatory factor X, 5 (influences HLA class II expression); targeted mutation 1.1, Irmgard Foerster |
MGI ID: |
MGI:2386501 |
Synonyms: |
RFX5- |
Gene: |
Rfx5 Location: Chr3:94861355-94868685 bp, + strand Genetic Position: Chr3, 40.74 cM, cytoband F2
|
Alliance: |
Rfx5tm1.1Ifo page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:67941
|
Parent Cell Line: |
E14.1 (ES Cell)
|
Strain of Origin: |
129P2/OlaHsd
|
|
Allele Type: |
|
Targeted (Null/knockout) |
Mutation: |
|
Intragenic deletion
|
|
|
Mutation details: The floxed region containing exons encoding the DNA binding domain (exons 4 through 7) and a neo cassette was excised via the expression of cre recombinase in vivo. RT-PCR and sequence analyses showed the deletion to result in the aberrant splicing of exon 3 to exon 8 and generate a frameshift mutation. A premature stop codon was identified, precluding the translation of a protein product longer than 77 residues, resulting in a truncated protein similar to mutant proteins identified in patients with MHC-II deficiency.
(J:67941)
|
|
|
Key: |
hm |
homozygous |
ht |
heterozygous |
tg |
involves transgenes |
√ |
phenotype observed |
cn |
conditional genotype |
cx |
complex: > 1 genome feature |
ot |
other: hemizygous, indeterminate,... |
N |
normal phenotype |
|
Genotype/ Background: |
| Allelic Composition | Genetic Background | Cell Line(s) |
---|
Loading... | | | involves: 129 * C57BL/6 | | | | involves: 129 * C57BL/6 * C.B-20 | |
|
Phenotypes: |
Affected Systems |
|
|
|
cardiovascular system
|
√
|
|
abnormal Kupffer cell morphology
|
√
|
|
endocrine/exocrine glands
|
√
|
|
abnormal thymus cortex morphology
|
√
|
|
hematopoietic system
|
√
|
√
|
abnormal Kupffer cell morphology
|
√
|
|
abnormal thymus cortex morphology
|
√
|
|
decreased CD4-positive, alpha-beta T cell number
|
√
|
|
decreased single-positive T cell number
|
√
|
|
abnormal dendritic cell morphology
|
√
|
|
abnormal B lymphocyte antigen presentation
|
√
|
|
decreased IgG1 level
|
√
|
|
decreased IgM level
|
√
|
|
abnormal MHC II cell surface expression on macrophages
|
√
|
√
|
immune system
|
√
|
√
|
abnormal Kupffer cell morphology
|
√
|
|
abnormal thymus cortex morphology
|
√
|
|
decreased CD4-positive, alpha-beta T cell number
|
√
|
|
decreased single-positive T cell number
|
√
|
|
abnormal dendritic cell morphology
|
√
|
|
abnormal B lymphocyte antigen presentation
|
√
|
|
decreased IgG1 level
|
√
|
|
decreased IgM level
|
√
|
|
abnormal level of surface class II molecules
|
√
|
|
abnormal MHC II cell surface expression on macrophages
|
√
|
√
|
liver/biliary system
|
√
|
|
abnormal Kupffer cell morphology
|
√
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Rfx5 Mutation: |
34 strains or lines available
|
|
Original: |
J:67941 Clausen BE, et al., Residual MHC class II expression on mature dendritic cells and activated B cells in RFX5-deficient mice. Immunity. 1998 Feb;8(2):143-55 |
All: |
4 reference(s) |
|